Trial intelligence / Profile preview

Effects of anxiety on neuropathic pain and pregabalin’s anxiety-modulating effects assessed with fMRI

2006-004464-31Phase 4Terminated

Sponsor
Eija Kalso
Start
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of pregabalin in Neuralgia and anxiety disorder, sponsored by Eija Kalso. Started Aug 2006; status: terminated.

02

Drugs

pregabalin
03

Conditions

Neuralgiaanxiety disorder

Beyond the preview

Go deeper on 2006-004464-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004464-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call